Suppr超能文献

抗白喉类毒素抗体的血清阳性率及其对越南中南部沿海地区疫苗接种政策的影响:一项横断面研究。

Seroprevalence of anti-diphtheria toxoid antibody and implications for vaccination policy in Vietnam's South-central coast: a cross-sectional study.

机构信息

Pasteur Institute in Nha Trang, Nha Trang, Khanh Hoa, Vietnam.

Department of Pediatric Infectious Diseases Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.

出版信息

BMC Infect Dis. 2024 Aug 12;24(1):813. doi: 10.1186/s12879-024-09688-0.

Abstract

BACKGROUND

Diphtheria is a re-emerging infectious disease and public health concern worldwide and in Vietnam with increasing cases in recent years. This study aimed to assess the anti-diphtheria toxoid antibodies status in Khanh Hoa Province and identify factors contributing to the vaccination policy in the south-central coast of Vietnam.

METHODS

This was a cross-sectional study to evaluate the seroprevalence of anti-diphtheria toxoid antibodies among 1,195 participants, aged 5 - 40 years in Khanh Hoa Province, Vietnam. Immunoglobulin G antibody levels against diphtheria were detected using a commercial anti-diphtheria toxoid enzyme-linked immunosorbent assay (SERION ELISA classic Diphtheria Immunoglobulin G) and were categorized following the World Health Organization guidelines.

RESULTS

The mean anti-diphtheria toxoid antibody levels were 0.07 IU/ml (95% Confidence Interval: 0.07-0.08). Anti-diphtheria toxoid antibody levels were found to be associated with age and history of diphtheria vaccination. The 5-15 years age group had the highest levels (0.09 IU/ml), while the older age group had the lowest antibody level (p < 0.001). Individuals who received three doses (adjusted Odds ratio: 2.34, 95%CI: 1.35 - 4.07) or 4 doses (adjusted Odds ratio: 2.45, 95%CI: 1.29 - 4.64) had a higher antibody level compared to those who received only one dose regardless of age.

CONCLUSION

It is crucial to promote routine vaccination coverage to over 95% for children under one year of age with three primary doses of the diphtheria-containing vaccine, including additional doses at 18 months and 7 years of age. Booster doses should be promoted and administered to adolescents and adults every 10 years.

摘要

背景

白喉是一种在全球范围内重新出现的传染病和公共卫生问题,在越南也是如此,近年来病例不断增加。本研究旨在评估庆和省抗白喉类毒素抗体状况,并确定导致越南中南部沿海地区疫苗接种政策的因素。

方法

这是一项横断面研究,评估了越南庆和省 1195 名 5-40 岁参与者对白喉类毒素抗体的血清阳性率。使用商业抗白喉类毒素酶联免疫吸附试验(SERION ELISA 经典白喉免疫球蛋白 G)检测对白喉的免疫球蛋白 G 抗体水平,并按照世界卫生组织的指南进行分类。

结果

平均抗白喉类毒素抗体水平为 0.07IU/ml(95%置信区间:0.07-0.08)。发现抗白喉类毒素抗体水平与年龄和白喉疫苗接种史有关。5-15 岁年龄组的抗体水平最高(0.09IU/ml),而年龄较大的组的抗体水平最低(p<0.001)。接受三剂(调整后的优势比:2.34,95%置信区间:1.35-4.07)或四剂(调整后的优势比:2.45,95%置信区间:1.29-4.64)的人,无论年龄大小,与仅接受一剂的人相比,抗体水平更高。

结论

对于 1 岁以下的儿童,必须促进常规疫苗接种覆盖率达到 95%以上,接种三剂含白喉的疫苗,包括在 18 个月和 7 岁时额外接种一剂。应促进和为青少年和成年人每 10 年接种一次加强剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d6/11318120/64cb589b5a18/12879_2024_9688_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验